InvestorsHub Logo

Poor Man -

08/11/22 11:15 PM

#504166 RE: jimmy667 #504159

What it really highlights is the conflict of interest between NWBO and Advent. When transactions are not arranged at arms length — in this case the same person controls both entities — there’s no way for shareholders to have confidence that those transactions maximize their interests. The notion that Advent has “skin the game” makes no sense since Toucan has ownership and complete control over both companies.

Imagine if Merck’s CEO began to enter into substantial financial agreements with some sidecar company that only he owned and controlled. Wouldn’t happen of course because of internal controls and policies for corporate ethics and conflicts of interest would make that highly improbable.

I actually know administrators in hospitals that don’t permit pharmaceutical salesmen to buy their lunch because of code of conduct policies.

biosectinvestor

08/12/22 12:14 AM

#504190 RE: jimmy667 #504159

Exactly right Jimmy.